Breaking Glioblastoma’s Defenses: Ohio State Researchers Identify the SET Protein as a Key Vulnerability in Deadly Brain Cancer
Executive Overview Glioblastoma (GBM) remains one of the most treatment-resistant and lethal forms of human cancer. For decades, the therapeutic landscape for patients diagnosed with this aggressive brain tumor has…
